Your browser doesn't support javascript.
loading
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
Meister, Michael T; Groot Koerkamp, Marian J A; de Souza, Terezinha; Breunis, Willemijn B; Frazer-Mendelewska, Ewa; Brok, Mariël; DeMartino, Jeff; Manders, Freek; Calandrini, Camilla; Kerstens, Hinri H D; Janse, Alex; Dolman, M Emmy M; Eising, Selma; Langenberg, Karin P S; van Tuil, Marc; Knops, Rutger R G; van Scheltinga, Sheila Terwisscha; Hiemcke-Jiwa, Laura S; Flucke, Uta; Merks, Johannes H M; van Noesel, Max M; Tops, Bastiaan B J; Hehir-Kwa, Jayne Y; Kemmeren, Patrick; Molenaar, Jan J; van de Wetering, Marc; van Boxtel, Ruben; Drost, Jarno; Holstege, Frank C P.
Affiliation
  • Meister MT; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Groot Koerkamp MJA; Oncode Institute, Utrecht, The Netherlands.
  • de Souza T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Breunis WB; Oncode Institute, Utrecht, The Netherlands.
  • Frazer-Mendelewska E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Brok M; Oncode Institute, Utrecht, The Netherlands.
  • DeMartino J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Manders F; Department of Oncology and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland.
  • Calandrini C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Kerstens HHD; Oncode Institute, Utrecht, The Netherlands.
  • Janse A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Dolman MEM; Oncode Institute, Utrecht, The Netherlands.
  • Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Langenberg KPS; Oncode Institute, Utrecht, The Netherlands.
  • van Tuil M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Knops RRG; Oncode Institute, Utrecht, The Netherlands.
  • van Scheltinga ST; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Hiemcke-Jiwa LS; Oncode Institute, Utrecht, The Netherlands.
  • Flucke U; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Tops BBJ; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.
  • Hehir-Kwa JY; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Kensington, NSW, Australia.
  • Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van de Wetering M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Boxtel R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
EMBO Mol Med ; 14(10): e16001, 2022 10 10.
Article in En | MEDLINE | ID: mdl-35916583
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Organoids Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Humans Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Organoids Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Humans Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: Country of publication: